Tag: IBM

DELRAY BEACH, Fla., June 5, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Smart Manufacturing Market is projected to reach USD 995.67 billion by 2032 from...

DELRAY BEACH, Fla., June 5, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Smart Manufacturing Market is projected to reach USD 995.67 billion by 2032 from...

New global challenge provides university students hands-on experience with IBM Bob, helping them build practical AI skills, portfolio-ready projects and career connectionsNEW YORK, June...

STOCKHOLM, June 2, 2026 /PRNewswire/ -- Arelion today announced the expansion of its Conflict-Free Channel Program in Mexico, leveraging its extensive network to support...

The growth of the Public Cloud Infrastructure Managed Service Market is driven by the increasing adoption of cloud technologies across industries, the rising need...

The growth of the Public Cloud Infrastructure Managed Service Market is driven by the increasing adoption of cloud technologies across industries, the rising need...

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of US Personalized Medicine Market size & share revenue was valued at approximately USD 56.37 Billion in 2024 and is expected to reach USD 66.13 Billion in 2025 and is expected to reach around USD 252.93 Billion by 2034, at a CAGR of 17.32% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Illumina Inc., Precision Biologics, Danaher Corporation (Cepheid Inc.), GE HealthCare, Celera Diagnostics LLC, Decode Genetics Inc., Exact Sciences Corporation, IBM Corporation, Exagen Inc., Biogen, QIAGEN, Genentech Inc., 23andMe Inc., Asuragen Inc and others.

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of US Personalized Medicine Market size & share revenue was valued at approximately USD 56.37 Billion in 2024 and is expected to reach USD 66.13 Billion in 2025 and is expected to reach around USD 252.93 Billion by 2034, at a CAGR of 17.32% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Illumina Inc., Precision Biologics, Danaher Corporation (Cepheid Inc.), GE HealthCare, Celera Diagnostics LLC, Decode Genetics Inc., Exact Sciences Corporation, IBM Corporation, Exagen Inc., Biogen, QIAGEN, Genentech Inc., 23andMe Inc., Asuragen Inc and others.

The digital health market is experiencing robust growth, driven by increasing adoption of telemedicine, wearable devices, and AI-powered health solutions. Rising healthcare costs and...

Seasoned sales leader with proven track record of scaling cybersecurity companies to lead worldwide go-to-market strategy NEW YORK, Aug. 12, 2025 /PRNewswire/ -- OX, a leader...

The smart cities market is anticipated to expand at a rapid pace due to rapid urbanization and escalating population. WESTFORD, Mass., Aug. 11, 2025 /PRNewswire/...

Dramatically Enhanced Program Streamlines Engagement and Empowers Partners to Fuel Profitable Growth, Technical Strength, and Differentiation  SINGAPORE, Aug. 8, 2025 /PRNewswire/ -- Cohesity, the leader...

Cybersecurity visionary joins New Charter to position the company at the forefront of intelligent, adaptive cybersecurity. DENVER, Aug. 4, 2025 /PRNewswire/ -- New Charter Technologies,...

Over 60% of Keynotes and Panels to Feature AI Innovation SANTA CLARA, Calif., Aug. 1, 2025 /PRNewswire/ -- FMS: the Future of Memory and Storage,...

KubeCon + CloudNativeCon North America returns Nov. 10–13 in Atlanta, bringing the global community together to celebrate CNCF's 10th anniversary and explore what's next...